Home / Publications

Publications

ANZUP and our members contribute to national and international publications, presentations and journals – highlighting the clinical research we undertake.

Trial

Year

JOURNAL

ScienceDirect

DATE

27/02/2024

TRIAL

Other

Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial

Authors
Prof Shankar Siva, Mathias Bressel, Mark Sidhom, Swetha Sridharan, Ben G L Vanneste, Ryan Davey, Rebecca Montgomerym, Jeremy Ruben, Prof Farshad Foroudi, Braden Higgs, Charles Lin, Avi Raman, Nicholas Hardcastle, Prof Michael S Hofman, Richard De Abreu Lourenco, Mark Shaw, Pascal Mancuso, Daniel Moon, Lih-Ming Wong, Nathan Lawrentschuk, Helen Frewen

JOURNAL

BJU International

DATE

03/02/2024

TRIAL

Other

The Dedicated Imaging Post-Prostatectomy for Enhanced Radiotherapy outcomes (DIPPER) trial protocol: a multicentre, randomised trial of salvage radiotherapy versus surveillance for low-risk biochemical recurrence after radical prostatectomy

Authors
Ciara Conduit, Ian D. Davis, Jeffrey C. Goh, Ganessan Kichenadasse1, Howard Gurney, Carole A. Harris, David Pook, Laurence Krieger, Francis Parnis, Craig Underhill, Diana Adams, Felicia Roncolato, Anthony Joshua, Tom Ferguson, Prashanth Prithviraj, Michelle Morris, Michelle Harrison, Stephen Begbie, Elizabeth Hovey, Mathew George, Elizabeth C. Liow, Emma K. Link, Margaret McJannett, Craig Gedye

JOURNAL

The Lancet

DATE

04/01/2024

TRIAL

TheraP

Overall survival with [¹⁷⁷Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial

Authors
Michael S Hofman, Louise Emmett, Shahneen Sandhu, Amir Iravani, James P Buteau, Anthony M Joshua, Jeffrey C Goh, David A Pattison, Thean Hsiang Tan, Ian D Kirkwood, Siobhan Ng, Roslyn J Francis, Craig Gedye, Natalie K Rutherford, Andrew Weickhardt, Andrew M Scott, Sze-Ting Lee, Edmond M Kwan, Arun A Azad, Shakher Ramdave, Andrew D Redfern, William Macdonald, Alex Guminski, Edward Hsiao, Wei Chua, Peter Lin, Alison Yan Zhang, Martin R Stockler, Scott G Williams, Andrew J Martin, Ian D Davis, for the TheraP Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group*

JOURNAL

BJU International

DATE

22/11/2023

TRIAL

Other

A phase II trial of nivolumab followed by ipilimumab and nivolumab in advanced non-clear-cell renal cell carcinoma

Authors
Ciara Conduit , Ian D. Davis, Jeffrey C. Goh, Ganessan Kichenadasse, Howard Gurney, Carole A. Harris David Pook Laurence Krieger, Francis Parnis,, Craig Underhill, Diana Adams, Felicia Roncolato, Anthony Joshua, Tom Ferguson, Prashanth Prithviraj Michelle Morris, Michelle Harrison, Stephen Begbie, Elizabeth Hovey, Mathew George, Elizabeth C. Liow, Emma K. Link, Margaret McJannett, Craig Gedye

JOURNAL

European Urology Oncology

DATE

07/10/2023

TRIAL

PCR MIB

Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502)

Authors
Andrew Weickhardt, Farshad Foroudi, Nathan Lawrentschuk, Jing Xie, Mark Sidhom, Abhijit Pal, Peter Grimiso, Alison Zhang, Siobhan Ng, Colin Tang, Elizabeth Hovey, Colin Chen, George Hruby, Alexander Guminski, Margaret McJannett, Ciara Conduit, Ben Tran, Ian D. Davis, Dickon Hayne

JOURNAL

BJU International

DATE

18/09/2023

TRIAL

Other

The Dedicated Imaging Post-Prostatectomy for Enhanced Radiotherapy outcomes (DIPPER) trial protocol: a multicentre, randomised trial of salvage radiotherapy versus surveillance for low-risk biochemical recurrence after radical prostatectomy

Authors
Matthew J. Roberts, Ciara Conduit, Ian D. Davis, Rachel M. Effeney, Scott Williams, Jarad M. Martin, Michael S. Hofman, George Hruby, Renu Eapen, Chris Gianacas, Nathan Papa, Richard De Abreu Lourenc Haryana M. Dhillon, Ray Allen, Antoinette Fontela, Baldeep Kaur, Louise Emmett.

JOURNAL

DATE

16/06/2023

TRIAL

Other

Patterns of Relapse in Australian Patients With Clinical Stage 1 Testicular Cancer: Utility of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Surveillance Recommendations

Authors
Ciara Conduit, Jeremy Lewin, Andrew Weickhardt, James Lynam, Shirley Wong, Peter Grimison, Shomik Sengupta, Ganes Pranavan, Francis Parnis, Patricia Bastick, David Campbell, Aaron R. Hansen, Matt Leonard, Margaret McJannett, Martin R. Stockler, Peter Gibbs, Guy Toner, Ian D. Davis, Ben Tran, and Anna Kuchel.

JOURNAL

JCO Oncology Practice

DATE

13/06/2023

TRIAL

CLIMATE

Patterns of Relapse in Australian Patients With Clinical Stage 1 Testicular Cancer: Utility of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Surveillance Recommendations

Authors
Ciara Conduit, Jeremy Lewin, Andrew Weickhardt, James Lynam, BSc(Hons), Shirley Wong, Peter Grimison, Shomik Sengupta, Ganes Pranavan, Francis Parnis, Patricia Bastick, David Campbell, Aaron R. Hansen, Matt Leonard, Margaret McJannett, Martin R. Stockler, Peter Gibbs, Guy Toner, Ian D. Davis, Ben Tran, and Anna Kuchel

JOURNAL

The Lancet

DATE

03/04/2023

TRIAL

ENZAMET

Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial

Authors
Christopher J Sweeney, Andrew J Martin, Martin R Stockler, Stephen Begbie, Leanna Cheung, Kim N Chi, Simon Chowdhury, Mark Frydenberg, Lisa G Horvath, Anthony M Joshua, Nicola J Lawrence, Gavin Marx, John McCaffrey, Ray McDermott, Margaret McJannett, Scott A North, Francis Parnis, Wendy Parulekar, David W Pook, Martin Neil Reaume, Shahneen K Sandhu, Alvin Tan, Thean Hsiang Tan, Alastair Thomson, Francisco Vera-Badillo, Scott G Williams, Diana Winter, Sonia Yip, Alison Y Zhang, Robert R Zielinski, Ian D Davis, for the ENZAMET trial investigators* and Australian and New Zealand Urogenital and Prostate Cancer Trials Group